Yanyang Tu

机构：Huizhou Central People's Hospital

发表论文 4 篇 · 总被引 56 次 · h-index 2

代表论文

• Hydrogel-based platforms for site-specific doxorubicin release in cancer therapy (2024 · Journal of Translational Medicine · 被引 45)
• Molecular drivers of epithelial-mesenchymal transition (EMT) in glioblastoma and impact on therapy resistance (2025 · Pathology - Research and Practice · 被引 9)
• Optimized federated learning framework with RegNetZ and Swin-Transformer for multimodal pancreatic cancer detection1 (2025 · Scientific Reports · 被引 2)
• REST-driven upregulation of SFXN3 promotes AML progression via Wnt/β-catenin activation and confers decitabine resistance (2026 · Translational Oncology)